News Chart Monte Rosa Therapeutics, Inc.

Stocks

GLUE

US61225M1027

Biotechnology & Medical Research

Market Closed - Nasdaq 00:00:00 25/09/2026 +04			5-day change	1st Jan Change
11.72 ^USD	-1.43%		-6.98%	-25.26%

09-08	Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon	MT
09-08	Monte Rosa Therapeutics Initiates Phase 2 Clinical Study for Vav1-Directed Molecular Glue Degrader MRT-6160	CI

a094652ad1c273.zTKcODseSgshP1U0y10sQCPDMK8kiuxtQ2Wl2jzM7m8.j3irfwNrBVF3bDF9oQ1lAnySeMprxdVAOlzRsQv6vgaEf95ZWVgje2RvGA~308914a47fc4d081fa542b3cdafbc3eb